Heart Surgery

Latest Issue of OR Manager
August 2022
Home Surgery/Specialties > Heart Surgery

FDA: Class I recall of Medtronic’s HVAD batteries

Editor's Note The Food and Drug Administration (FDA), on June 23, identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) batteries as Class I, the most serious. The recall for a single lot (Model Number:1650DE) of HVAD batteries was initiated because of welding defects that allow separation…

Read More

By: Judy Mathias
June 27, 2022
Share

FDA: Class I recall of Medtronic HVAD Pump Implant Kit

Editor's Note The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants. The Kit was recalled because of a…

Read More

By: Judy Mathias
June 9, 2022
Share

Collateral damage of COVID-19 on CV services

Editor's Note This systematic review and meta-analysis led by researchers in the UK finds that across the world, cardiovascular (CV) services were severely disrupted, and as a result cardiac disease is expected to worsen, and repercussions will be felt for years to come. This analysis spans 2 years (2020 to…

Read More

By: Judy Mathias
June 1, 2022
Share

Sponsored Message

UW Medicine conducting national clinical trial on inflatable tubular stent

Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…

Read More

By: Tarsilla Moura
May 26, 2022
Share

The Joint Commission, AHA launch Comprehensive Heart Attack Center certification program

Editor's Note The Joint Commission and the American Heart Association, on April 20, announced the launch of a Comprehensive Heart Attack Center certification program, which recognizes hospitals providing care to the most complex and critically ill patients. To be certified, hospitals must provide 24-hours-a-day, 7-days-a-week on-site coverage for primary percutaneous…

Read More

By: Judy Mathias
April 21, 2022
Share

Key items for cardiovascular, peripheral vascular service lines

Ambulatory surgery centers (ASCs) are ramping up cardiovascular and peripheral vascular service lines, as Medicare offers payment for a growing number of cardiac procedures and accrediting bodies offer support for this methodology. In 2021, the Medicare Payment Advisory Commission reported that the number of ASCs billing Medicare for cardiology procedures…

Read More

By: Jennifer Lubell
March 25, 2022
Share

Sponsored Message

A systemic approach to cardiac service line safety

Among Surgical Care Affiliates’ (SCA) 260-plus facilities in the US, at least 10% have added cardiovascular/peripheral vascular service capabilities. SCA experts anticipate more growth in this area. However, any successful launch starts with an organizational focus on patient safety, says Ezra Erb, vice president for clinical quality at SCA, which…

Read More

By: Jennifer Lubell
March 25, 2022
Share

Report: Cardiology is fastest growing ASC specialty

Editor's Note According to the 2022 Key ASC Benchmarks and Industry Figures report published by Avanza Healthcare Strategies, an ASC consulting firm, cardiology is the fastest growing ASC specialty, Becker’s ASC Review March 10 reports. The Avanza report was released on March 8 and is a “compilation of recently [as…

Read More

By: Tarsilla Moura
March 10, 2022
Share

2-year outcomes of TAVR vs surgical AVR in low-risk patients

Editor's Note In this study, researchers report the 2-year outcomes for patients enrolled in the Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients), which show that transcather aortic valve replacement (TAVR) with a supra-annular, self-expanding valve is noninferior to surgical aortic valve replacement (AVR).…

Read More

By: Judy Mathias
March 8, 2022
Share

10-year outcomes of off-pump vs on-pump CABG in Department of Veterans Affairs patients

Editor's Note This multi-center, randomized, clinical trial that compares on-pump coronary artery bypass grafting (CABG) with off-pump CABG finds no advantage for off-pump CABG. A total of 2,203 veterans were randomly assigned to off-pump (1,104) or on-pump (1,099) CABG procedures at 18 VA medical centers, and the veterans were then…

Read More

By: Judy Mathias
February 17, 2022
Share
Live chat by BoldChat